Viewing Study NCT06095492


Ignite Creation Date: 2025-12-24 @ 3:39 PM
Ignite Modification Date: 2025-12-27 @ 12:08 PM
Study NCT ID: NCT06095492
Status: RECRUITING
Last Update Posted: 2024-12-05
First Post: 2023-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
Sponsor: Medanta, The Medicity, India
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module